TY - JOUR
T1 - Intermittent absent end diastolic velocity of the umbilical artery
T2 - Antenatal and neonatal characteristics and indications for delivery
AU - Rosner, J.
AU - Rochelson, B.
AU - Rosen, L.
AU - Roman, A.
AU - Vohra, N.
AU - Tam Tam, H.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Objective: To check whether there is a difference in indications for delivery, antepartum and neonatal characteristics in intermittent absent end diastolic velocity (iAEDV) compared to persistent absent or reversed end diastolic velocity (pA/REDV). Methods: A retrospective study of 109 patients with iAEDV or pA/REDV from 19 to 39 weeks. The delivery indication was classified as maternal or fetal. The primary antepartum and maternal characteristics were age, parity, AMA, chronic hypertension, PEC, thrombophilia, lupus, diabetes, smoker, placenta previa, gestational age (GA) at diagnosis of IUGR and/or SGA, GA at diagnosis of elevated S/D, iAEDV or pA/REDV, GA at delivery, minimal/absent variability day of delivery, BPP≤6 prior to delivery. The primary neonatal outcomes were birth weight, arterial cord pH, neonatal demise, necrotizing enterocolitis, intraventricular hemorrhage and length of stay in the NICU. Results: Fetuses with iAEDV were diagnosed with an elevated S/D at a later GA (29.6 vs. 27.5 weeks, p<0.03), delivered at a later GA (31.6 vs. 29.7 weeks, p<0.01), had a higher birth weight (1336.6 vs. 933g, p<0.0004), were more likely to be delivered for maternal indications (42.9% vs. 20.27%, p<0.01), had a higher cord arterial pH (7.28 vs. 7.21, p<0.002) and were less likely to have an arterial pH at birth <7.2 (0% vs. 34.1%, p<0.002). Conclusions: Although fetuses with iAEDV have an improved antenatal course as compared with pA/REDV, indications for delivery are more likely to be maternal and adverse outcome is common.
AB - Objective: To check whether there is a difference in indications for delivery, antepartum and neonatal characteristics in intermittent absent end diastolic velocity (iAEDV) compared to persistent absent or reversed end diastolic velocity (pA/REDV). Methods: A retrospective study of 109 patients with iAEDV or pA/REDV from 19 to 39 weeks. The delivery indication was classified as maternal or fetal. The primary antepartum and maternal characteristics were age, parity, AMA, chronic hypertension, PEC, thrombophilia, lupus, diabetes, smoker, placenta previa, gestational age (GA) at diagnosis of IUGR and/or SGA, GA at diagnosis of elevated S/D, iAEDV or pA/REDV, GA at delivery, minimal/absent variability day of delivery, BPP≤6 prior to delivery. The primary neonatal outcomes were birth weight, arterial cord pH, neonatal demise, necrotizing enterocolitis, intraventricular hemorrhage and length of stay in the NICU. Results: Fetuses with iAEDV were diagnosed with an elevated S/D at a later GA (29.6 vs. 27.5 weeks, p<0.03), delivered at a later GA (31.6 vs. 29.7 weeks, p<0.01), had a higher birth weight (1336.6 vs. 933g, p<0.0004), were more likely to be delivered for maternal indications (42.9% vs. 20.27%, p<0.01), had a higher cord arterial pH (7.28 vs. 7.21, p<0.002) and were less likely to have an arterial pH at birth <7.2 (0% vs. 34.1%, p<0.002). Conclusions: Although fetuses with iAEDV have an improved antenatal course as compared with pA/REDV, indications for delivery are more likely to be maternal and adverse outcome is common.
KW - End diastolic velocity
KW - Growth restriction
KW - Indications for delivery
KW - Pregnancy
KW - Umbilical artery Doppler
UR - http://www.scopus.com/inward/record.url?scp=84889689638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889689638&partnerID=8YFLogxK
U2 - 10.3109/14767058.2013.806475
DO - 10.3109/14767058.2013.806475
M3 - Article
C2 - 23682642
AN - SCOPUS:84889689638
SN - 1476-7058
VL - 27
SP - 94
EP - 97
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 1
ER -